Christopher Ryan Sullivan
CIK 1810417 · Chief Financial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$795.9K
Companies
2
Total Filings
24
Lifetime Open-Market Net
-$1.87M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Financial Officer | 40,773 | $19.52 | $795.9K | -$1.89M | 17 | 2026-06-12 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Interim CFO | 8,049 | $2.93 | $23.6K | $18.3K | 3 | 2021-01-28 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-02 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2025-12-12 | AVTX | Tax (F) | −155 | -$636 | EDGAR |
| 2025-04-01 | AVTX | Mixed | +16,915 | -$61.6K | EDGAR |
| 2025-01-30 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | AVTX | Buy (P) | +511 | $1.7K | EDGAR |
| 2023-05-17 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2023-02-15 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2022-10-07 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2022-03-10 | AVTX | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.